Biogen
Clinical trials sponsored by Biogen, explained in plain language.
-
Halted trial tests new shot at slowing devastating ALS
Disease control TerminatedThis study tested an experimental drug called BIIB105 in adults with ALS (amyotrophic lateral sclerosis). The drug was designed to lower levels of a protein linked to the disease and was given via spinal injection. The main goals were to check the drug's safety and see if it coul…
Phase: PHASE1, PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New MS injection trial aims to halt brain damage
Disease control TerminatedThis study tested a version of an existing MS drug, natalizumab, given as a shot under the skin every four weeks. It aimed to see if this new method of delivery could effectively reduce new brain lesions and relapses in Japanese adults with relapsing-remitting MS. The trial also …
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Feb 10, 2026 13:55 UTC